Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
3.83M
-
Shares change
-
+1.67M
-
Total reported value, excl. options
-
$8.04M
-
Value change
-
+$3.51M
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$2.10
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2018
7 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q4 2018.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.83M shares
of 47.6M outstanding shares and own 8.04% of the company stock.
Largest 8 shareholders include Blackstone Group L.P. (1.67M shares), Omega Fund Management, LLC (1.08M shares), BVF INC/IL (580K shares), EVENTIDE ASSET MANAGEMENT, LLC (482K shares), CIBC World Markets Inc. (10.1K shares), ROYAL BANK OF CANADA (2.35K shares), Tower Research Capital LLC (TRC) (0 shares), and Laurel Wealth Advisors LLC (600 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.